Wednesday, October 27, 2021
Wednesday, October 27, 2021
More

    French Research Indicates Nicotine Blocks COVID-19 from ‘Entering Cells and Spreading’
    F

    Your Content is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published.

    Get Your Content. Daily.

    Be the first to know about the biggest stories as they break. Sign up for breaking news email alerts from Your Content.

    France is the first country to limit the sale of nicotine products to avoid hoarding after research suggests it could prevent coronavirus, Your Content has learned. The online sale of nicotine products, specifically patches, chewing gum and lozenges have been restricted completely.

    The ban was initially an effort to “prevent the health risks of excessive consumption or misuse linked to media coverage of the possible protective effect of nicotine against COVID-19,” according to French officials.

    - Advertisement -

    “Secondly, it guarantees continuous and appropriate supply to people requiring medical support to stop smoking.”

    Researchers at an elite Paris hospital released a study Wednesday, noting only five percent of nearly 500 coronavirus patients smoked, far less than the 35 percent in France’s general population, according to MailOnline.

    Chart obtained by the MailOnline depicts the bizarre research done by the Chinese before the French had a clue. Photo Credit: WHO

    The study’s co-author, neurobiologist Jean-Pierre Changeux from France’s Pasteur Institut says the theory is that nicotine could adhere to cell receptors, thereby blocking the virus from entering cells and spreading in the body.

    In a bizarre twist, the researchers determined that far fewer smokers appear to have contracted the virus.

    - Advertisement -

    What’s more, if they contracted the virus, their symptoms are less serious. 

    Another study, by the Centers for Disease Control in the US, found just 1.3 per cent of hospitalized patients were smokers – compared to 14 per cent of America. 

    Chart obtained by the MailOnline depicts the bizarre research done by the French. Photo Credit: Center for Disease Control and Prevention

    “This preliminary analysis does not support the argument that current smoking is a risk factor for hospitalisation for COVID-19,” the researchers began.

    “Instead, these consistent observations, which are further emphasised by the low prevalence of current smoking among COVID-19 patients in the US (1.3 per cent), raises the hypothesis that nicotine may have beneficial effects on COVID-19.”

    The researchers admitted: “The accuracy of the recorded smoking status needs to be determined.”

    Professor Balloux came across the research paper and commented: “Whilst the study design is far from perfect – and the authors are clear about its limitations – the evidence for a protective effect of smoking (or nicotine) against COVID-19 is bizarrely strong.”

    - Advertisement -